跳至主要内容
临床试验/ACTRN12618000690257
ACTRN12618000690257撤回3 期

A Prospective PreecLampsia/Eclampsia Prevention Intervention (APPLE PIE): A randomised controlled trial determining the effect of esomeprazole on the incidence of preeclampsia in a cohort of nulliparous, high BMI women.

niversity of Melbourne (through its Department of Obstetrics and Gynaecology)0 个研究点目标入组 5,500 人开始时间: 2018年4月27日最近更新:

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
5,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Nulliparous
  • BMI of =>30 kg/m² at hospital booking visit
  • 12 - 20 weeks of pregnancy at the time of recruitment
  • Singleton pregnancy
  • Age 18 and above
  • Able to comprehend study information

排除标准

  • Patient is unable or unwilling to give consent
  • Known/suspected major fetal malformation or infection
  • Any current use of a PPI
  • Contraindications to the use of esomeprazole
  • Pre-existing renal impairment
  • Pre-existing hepatic impairment
  • HIV, Hepatitis B, or Hepatitis C positive

研究者

发起方
niversity of Melbourne (through its Department of Obstetrics and Gynaecology)

相似试验